greenbelka-shutterstock-com
GreenBelka / Shutterstock.com
7 July 2016Asia-PacificGareth Morgan

From the EU to Australia: latest SPC developments

In an article in March I highlighted that the supplementary protection certificate (SPC) regime in the EU is currently coming under scrutiny in terms of its industry sector application and the scope of the right that is granted. Recent events have progressed each of these initiatives and it is therefore necessary to update the article. The current legislative activity in the EU is also reviving discussion around similar provisions in other countries around the world.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
1 March 2016   The European Commission is considering whether ‘export waivers’ should be introduced in order to partly relax the rules on supplementary protection certificates. Gareth Morgan of Olswang explains more.

More on this story

Big Pharma
1 March 2016   The European Commission is considering whether ‘export waivers’ should be introduced in order to partly relax the rules on supplementary protection certificates. Gareth Morgan of Olswang explains more.

More on this story

Big Pharma
1 March 2016   The European Commission is considering whether ‘export waivers’ should be introduced in order to partly relax the rules on supplementary protection certificates. Gareth Morgan of Olswang explains more.